Jump to main content
Jump to site search

Issue 23, 2015
Previous Article Next Article

Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

Author affiliations

Abstract

Dithiomaleimide-based camptothecin-containing nanoparticles are designed to have exceptionally high drug loading and are capable of reduction-responsive, FRET-indicated drug release.

Graphical abstract: Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

Back to tab navigation

Supplementary files

Publication details

The article was received on 07 Jan 2015, accepted on 05 Feb 2015 and first published on 18 Feb 2015


Article type: Communication
DOI: 10.1039/C5CC00148J
Citation: Chem. Commun., 2015,51, 4807-4810
  •   Request permissions

    Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug release

    H. Wang, M. Xu, M. Xiong and J. Cheng, Chem. Commun., 2015, 51, 4807
    DOI: 10.1039/C5CC00148J

Search articles by author

Spotlight

Advertisements